Presentation ACC 2025 Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial Presenter: Saibal Kar March 30, 2025
Presentation ACC 2025 Dapagliflozin after Transcatheter Aortic Valve Implantation Presenter: Sergio Raposeiras-Roubin March 29, 2025
Presentation ACC 2023 Transcatheter vs Surgical Aortic Valve Replacement in Low RiskPatients: 3-Year Outcomes from the EvolutLow Risk Trial Presenter: John K. Forrest March 05, 2023
Presentation ACC 2023 A Landmark Randomized Clinical Trial of Transcatheter Repair for Tricuspid Regurgitation Presenter: Paul Sorajja March 05, 2023
Presentation ACC 2023 5-Year Follow-Up After Transcatheter Repair of Secondary Mitral Regurgitation The COAPT Trial Presenter: Gregg W. Stone March 05, 2023
Presentation ACC 2022 Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial Presenter: Duk-Woo Park April 04, 2022
Presentation ACC 2022 5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials Presenter: Michael J. Reardon April 04, 2022
Presentation ACC 2019 Health Status after Transcatheter Mitral- Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial Presenter: Suzanne V. Arnold March 18, 2019
Presentation ACC 2019 PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis Presenter: Martin B. Leon March 17, 2019
Presentation ACC 2016 Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis Presenter: Craig R. Smith April 03, 2016
Presentation ACC 2016 Relationship Between Procedure Volume and Outcome for Transcatheter Aortic Valve Replacement in U.S. Clinical Practice: Insights from the STS-ACC TVT Registry Presenter: John D. Carroll April 03, 2016
Presentation ACC 2016 3-Year Results From the CoreValve US Pivotal High Risk Randomized Trial Comparing Self-Expanding Transcatheter and Surgical Aortic Valves Presenter: Michael Deeb April 03, 2016
Presentation ACC 2016 SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis Presenter: Vinod Thourani April 01, 2016
Presentation ACC 2015 Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Presenter: Michael J. Mack March 15, 2015
Presentation ACC 2015 A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes Presenter: Michael J. Reardon March 15, 2015
Presentation ACC 2014 Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Disease Presenter: Darren Mylotte March 30, 2014
Presentation ACC 2013 Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients with Severe Aortic Stenosis Presenter: Vinod H. Thourani March 11, 2013
Presentation ACC 2013 New Data from the PARTNER Non-Randomized Continued Access Registry: Outcomes After Transfemoral Transcatheter Aortic Valve Replacement Presenter: William F. Fearon March 11, 2013
Presentation ACC 2013 Impact of Sex on Outcomes Following Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Insights From The PARTNER Experience Presenter: Ajay J. Kirtane March 11, 2013
Presentation ACC 2013 Paravalvular Leaks Post-Transcatheter Aortic Valve Replacement Presenter: Philippe Généreux March 09, 2013